Cidara Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Cidara Therapeutics (Nasdaq: CDTX) announced the participation of Jeffrey Stein, Ph.D., in four upcoming investor conferences in September 2020. Key events include:

• Citi’s 15th Annual BioPharma Conference: September 9, 2020
• H.C. Wainwright 22nd Annual Global Investment Conference: September 14, 2020, at 4:30 PM ET
• Cantor Fitzgerald Virtual Global Healthcare Conference: September 16, 2020, at 3:20 PM ET
• Maxim Conference: September 17, 2020, at 11:00 AM ET

Webcasts available on the company’s website.

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will participate in four investor conferences in September: Citi’s 15^th Annual BioPharma Conference, H.C. Wainwright 22^nd Annual Global Investment Conference, Cantor Fitzgerald Virtual Global Healthcare Conference, and Maxim Conference: A Too Quiet Pandemic – Fungal Disease.

Citi’s 15th Annual BioPharma Conference
Date:		Wednesday, September 9, 2020
1x1 meetings only
H.C. Wainwright 22nd Annual Global Investment Conference
Date:		Monday, September 14, 2020
Time:		4:30 PM Eastern Time
Cantor Fitzgerald Virtual Global Healthcare Conference
Date:		Wednesday, September 16, 2020
Time:		3:20 PM Eastern Time
Maxim Conference: A Too Quiet Pandemic – Fungal Disease
Date:		Thursday, September 17, 2020
Time:		11:00 AM Eastern Time

A live audio webcast and replay of the presentations at the H.C. Wainwright and Cantor Fitzgerald-sponsored events will be available in the Investors section on the Company’s website at www.cidara.com.

About Cidara Therapeutics
Cidara is developing long-acting therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak® antiviral platform. Cidara is headquartered in San Diego, California. For more information, please visit www.cidara.com.

INVESTOR CONTACT:
Brian Ritchie
LifeSci Advisors
(212) 915-2578
britchie@lifesciadvisors.com

MEDIA CONTACT:
Karen O’Shea, Ph.D.
LifeSci Communications
(929) 469-3860
koshea@lifescicomms.com

FAQ

What conferences will Cidara Therapeutics participate in September 2020?

Cidara Therapeutics will participate in Citi’s 15th Annual BioPharma Conference, H.C. Wainwright 22nd Annual Global Investment Conference, Cantor Fitzgerald Virtual Global Healthcare Conference, and Maxim Conference in September 2020.

When is the H.C. Wainwright Conference for Cidara Therapeutics?

The H.C. Wainwright 22nd Annual Global Investment Conference will take place on September 14, 2020, at 4:30 PM Eastern Time.

What time is the Cantor Fitzgerald Conference for Cidara Therapeutics?

The Cantor Fitzgerald Virtual Global Healthcare Conference is scheduled for September 16, 2020, at 3:20 PM Eastern Time.

When will Cidara Therapeutics present at the Maxim Conference?

Cidara Therapeutics will present at the Maxim Conference on September 17, 2020, at 11:00 AM Eastern Time.

Where can I find the webcast for Cidara Therapeutics' presentations?

Live audio webcasts for the H.C. Wainwright and Cantor Fitzgerald events will be available in the Investors section of Cidara Therapeutics' website.